General Medicine

Click here to read this study in JAMA. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...

Key Points: 1. Schrödinger discontinued its SGR-2921 CDC7 inhibitor program following two treatment-related deaths in a Phase 1 trial. 2. AML patients...

Click here to read this study in NEJM. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent...

Key Points: 1. GSK paid $500 million upfront for global development rights to Hengrui’s portfolio of up to 12 early-stage assets. 2. Includes a PDE3/4...

1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alo...

1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months, particular...

Click here to read this study in the Lancet. ©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written c...

Key Points: 1. First FDA-approved therapy for non-cystic fibrosis bronchiectasis; addresses a major unmet respiratory need. 2. Phase 3 data showed sig...

GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 Diabetes 1. In this cohort of individuals with type 2 d...

Key Points: 1. Deal worth up to $1.3 billion brings AI-powered GPCR target discovery into Lilly’s obesity and cardiometabolic pipeline. 2. Superlumina...